INTRODUCTION
There has been a growing interest in the development of high-throughput screening technologies over the last few decades [1] , largely because screening methods promoted by the pharmaceutical industry have played a key role in drug discovery. The increasing computing power and miniaturization of screening equipment now allow for carrying out high-throughput screening analyses even in small academic laboratories. The most popular screening technologies used in drug design are high-content screening (HCS) [2] and high-throughput screening (HTS) [3] . Their different subcategories include small molecule [4] , complementary DNA (cDNA) [5] and RNA interference (RNAi) [6] types of screening. In a typical HCS or HTS campaign, hundreds of terabytes of experimental data concerning molecule activity, specificity, and physiological and toxicological properties can be generated. These data should be processed using appropriate data mining and statistical methods and protocols in order to identify promising drug candidates (i.e., hits). One of the key challenges that needs to be answered during the analysis of HCS and HTS data is the identification and successful elimination of bias (i.e., systematic error) in the measurements. In this review, we discuss the existing types of bias common to all high-throughput screening technologies and discuss their negative impact on the hit selection process. We underline the necessity of randomization of screened samples and indicate the advantages of using replicate measurements. We present the methods intended to detect systematic error and those designed to correct the data affected by it. We argue that the latter methods should be applied only when the presence of a specific type of systematic error in the data has been confirmed by a suitable statistical test [7] . Furthermore, we provide suggestions concerning which data normalization and correction techniques should be applied in various practical situations. Finally, we present a broad-spectrum data pre-processing protocol that can be used for the correction and analysis of screening data prior to assay quality estimation and hit selection steps. This protocol can also be used for detecting and removing bias in future HTS technologies involving sequential screening of multiple plates. To illustrate the results of our analyses, we examine publically available HTS and HCS data generated at the McGill University HTS laboratory (Figure 1 
SCREENING TECHNOLOGIES and RELATED BIASES HTS and HCS technologies and their subcategories
In this review, we focus on the two most widely used screening technologies: High-throughput screening (HTS) and high-content screening (HCS). In a typical HTS/HCS primary assay, the 3 selected library of chemical compounds is screened against a specific biological target to measure the intensity of the related inhibition or activation signal [8] . The size of the compound library can vary from hundreds to millions of items. Compounds are allocated across disposable microtiter plates of different sizes, typically including 96, 384 or 1536 wells. Well locations within a plate follow a rectangular matrix pattern. Each compound is usually placed in a single well. A suitable biological target culture (e.g., cells or a bacterial enzyme) is then added to each well of the plate. It is common to conduct unreplicated HTS experiments, although, as we show next, it is much more appropriate to obtain at minimum duplicate measurements. Processing the assay plates by HTS robotic equipment consists of a number of experimental wet-lab steps, including incubation, rising, and reagent additions to the biological culture of interest. Once the incubation period is over, the plates are scanned to obtain measures of biological activity characterizing the selected compounds. It is worth noting that the obtained raw activity levels depend not only on putative biological activity, but also on systematic and random errors affecting the given screen. Data analysis steps, including statistical procedures for data normalization and data correction, should then be carried out to identify hits.
The increasing capacity of computer storage devices along with improvements in automation have allowed the use of HTS technologies to achieve resolution at the cellular level [9] . This related technology is called high-content screening (HCS). HCS is a screening method with multiple readouts that is based on microscopic imaging from a cell-based assay [10] . HCS obtains detailed information of cell structure by extracting multicolor fluorescence signals. HCS has three advantages relative to other screening techniques: (a) Cell-based analysis achieves high physiological correspondence, especially regarding drug screening; (b) Single cell analysis captures the heterogeneity of cell populations as well as the related individual response to treatments; (c) HCS generally has low false-positive and false-negative rates [11] . Thus, HCS technologies are commonly used in all areas of contemporary drug discovery, including primary compound screening, post-primary screening capable of supporting structure-activity relationships, early evaluation of ADME properties and complex multivariate drug profiling [12] . The Mytocheck [13] and ChemBank [14] databases are among the rare online resources containing publically available HCS data.
Different subcategories of HTS and HCS technologies exist, depending on the target of interest.
They comprise altering protein function using small molecules, increasing gene function using cDNA libraries and manipulating gene function using RNAi.
(1) Small molecules: A "small molecule", which can be either natural or artificial, is defined in pharmacology as a molecule associated with a particular biopolymer -for example a nucleic 4 acid or a protein [15] . There is currently a significant interest in extending efforts to discover small molecules targeting proteins encoded in the genomes of humans and pathogenic organisms [16] . Furthermore, small-molecule screening technologies have applications in other areas of drug discovery, such as target validation, assay development, secondary screening, pharmacological property assessment and lead optimization. The combination of principles of molecular pharmacology with modern high-throughput [4] and high-content [17] technologies is critical for the success of these discoveries.
(2) cDNA library: High quality, full-length cDNA libraries are essential for discovery and validation of novel drug targets in functional genomic applications [18] . The discovery of reverse transcriptase permitted the transformation of unstable mRNA molecules into stable complementary DNA (cDNA) molecules. A comprehensive review of cDNA HCS can be found in [19] , and that of cDNA HTS in [5, 20] .
(3) RNA interference (RNAi): In the past decade, RNA interference (RNAi) has made great progress, evolving from a biological phenomenon into an effective method of drug discovery [21] . The two main advantages of RNAi screens compared to classical genetic screens are: (a) sequences of all identified genes are instantaneously identified and (b) lethal mutations are simple to determine because mutant recovery is not required [22] . The four types of RNAi reagents currently used in cell-based HTS are the following: dsRNAs, siRNAs, shRNAs and endoribonuclease-prepared siRNAs (esiRNAs) [23] . An important issue in genome-wide RNAi investigation is to combine both experimental and computational approaches to obtain highquality RNAi HTS assays and to overcome off-target effects [24] [25] [26] . A recent review by Knapp and Kaderali focuses on the analysis of RNAi HCS data and presents an approach for statistical processing of high-content microscopic screens [27] .
Systematic error in screening technologies
As with all biotechnologies, screening data are prone to both random and systematic errors.
Random error, which varies among measured HTS compounds, lowers screening precision and likewise affects false positive and false negatives rates. Its adverse effects can be greatly minimized by obtaining at least duplicate measurements [28] . Systematic error (i.e., systematic or spatial bias) can be defined as the systematic under or over-estimation of measurements taken at the same plate or assay location [29] . Systematic errors can be the cause of nonspecific phenotypes in specific well, row or column locations and thus lead to higher false positive and false negative rates [7, 30] . Its adverse effects can be minimized by the application of data correction methods and study design procedures such as randomization and blocking [8, 31] .
Systematic error can be due to various technological and environmental factors, such as robotic failure, reader effect, pipette malfunctioning or other liquid handling anomalies, unintended differences in compound concentration related to agent evaporation, variation in the incubation time or temperature difference, as well as lighting or air flow abnormalities present over the course of the screening campaign [32, 33] . Thus, bias causing systematic under-or overestimation of biological activity measurements can cause some inactive compounds to be incorrectly identified as hits (i.e., false positives) and some active compounds to remain undetected (i.e., false negatives). Systematic error can be well, row or column dependent. It can affect compounds placed either to the same well, row or column location over all plates of the assay (i.e., assay-specific error) or those located in a particular row or column of a single plate (i.e., plate-specific error) [34] .
Some specific positional effects appearing in HTS/HCS screens as a consequence of bias are summarized below. One often overlooked hurdle of HTS technologies is the batch effect [35] . A batch effect, i.e., bias present in some continuous subsets of the data and absent in others, occurs when some continuous groups of plates are affected by laboratory conditions which vary during the experiment. Although batch effects are hard to detect in low-dimensional assays, HTS technologies provide enough data to detect and remove them [35] . The edge effect, also called border effect, is another type of systematic error that consists in systematic under or overestimation of the measurements located on the plate's edges. Carralot et al. [36] indicated that although most repetitive errors in RNAi HTS can be generally controlled, some biases, such as edge effects, cannot be easily corrected due to well-to-well discrepancies inherent in the spatial structure of the plate. The cause of this effect is often unclear but medium evaporation or uneven treatment of the entire plate surface might be contributing factors [37] . Similarly to the platespecific edge effect, a more general assay-specific row, column, or well location effects can occur in both HTS and HCS screens when the data located in a particular row, column or well location are systematically over or under-estimated across all the plates of the assay. On the other hand, a systematic intra-image bias, consisting of the microscope-related errors, arises while capturing images in HCS. One of the issues here is a non-uniformity of background light intensity distribution, which is a slowly varying and systematic change of the spatial distribution of light in images. Such an effect can add or subtract intensities at any pixel location, thus affecting cell segmentation and florescence measurements, which, in turn, affect data quantification and statistical analysis [38] .
Cell population context can also create systematic bias in high-content cellular screens and thus significantly influence results of HCS campaigns [39] . A method allowing for normalizing and scoring statistically microscopy-based RNAi screens has been recently proposed [40] . This Figure 1a illustrates the presence of edge effects (e.g., the measurements in column 2 are systematically overestimated) in the Harvard 164-plate assay [29, 41] . This assay consists of a screen of compounds inhibiting the glycosyltransferase MurG function of E. coli. Here, the binding effect of MurG to a fluorescent (fluorescein-labeled) analogue of UDP-GlcNAc was estimated. In this example, the threshold of μ-2σ was applied to identify hits. The HTS Corrector software [42] was used to calculate raw ( Figure 1a) and B-score corrected (Figure 1b Similarly, image non-uniformity bias in HCS can be approximated and corrected by combining multiple images to generate a single image with an expected random spatial distribution of intensity values [38] . Such an approximation represents the overall effect of bias on the imaging field estimated using an image-averaging technique [43] . This positional bias can be detected by comparing the center of the image to its edges. In most cases, there is at least a two-fold increase in brightness between center and edges. 
METHODS and RESULTS

Data randomization and use of controls
The primary aim of statistical practice consists in estimating experimental error, and in the case of systematic error, in reducing the negative effect of this error [44] . Experimental design and statistical analysis methods should be applied to accomplish these objectives, although often underused in screening practice [31] . A fundamental approach for error reduction in experimental design must include control and randomization techniques [45] ; R.A. Fisher introduced the concept of randomization in which experimental units are assigned to groups or treatment in a manner that the probability of assignment to any particular group or treatment is equal and unbiased [46] . The main advantage of randomization in screening technologies is that randomized experimental units can distribute the error in a way that does not introduce 7 discrepancies to the experiment [31, 47, 48] . Thus, order of plate processing and compound placements both within each plate and across replicate plates of HTS/HCS assays should be randomized in order to reduce the impact of systematic bias on the outcome of screening experiments.
Controls contain compounds with well-known biological activity. Positive controls provide maximum possible activity measurements and negative controls provide minimum possible activity measurements. Controls are used in control-based normalization methods to render the screening data comparable across different plates and to establish assay background levels.
Ideally, controls should be located randomly within plates, but in practice, only the first and the last columns of the plate are typically available for controls. The related systematic edge effect can be reduced by alternating the positive and negative controls in the available wells, so that they appear equally on each of the plate's rows and columns [8] . If the edge effect affects the control wells, it will also affect all of the plate's measurements because they are normalized relative to the control activities. Randomization of the position of compounds in the replicated experiments is also very important, but unfortunately, is often limited due to practical considerations when automatic spotting approaches or some of the available statistical pipelines (e.g., cellHTS in BioConductor [49] ) not supporting control randomization are used. RNAi controls generally exhibit more inter-well variability than small molecule controls because of variations in transfection efficiencies [50] . Cell-based biological controls are especially problematic because cell clumping or evaporation within different plate areas can lead to different growth conditions and thus to position-related bias [8, 36] .
Advantages of replicated measurements
Replicates offer the twin advantage of obtaining a greater precision of activity measurements and that of estimating the measurements variability [8] . The use of replicates allows one to reduce the uncertainty associated to a single measurement (i.e., standard error of the mean), as indicated in Formula 1:
where n is the number of replicates. Thus, carrying out two replicated screens reduces imprecision by 29%; carrying out three replicated screens reduces impression by further 13%;
and, carrying out four replicated screens reduces the impression by additional 8% (i.e., eliminating in total 50% of imprecision associated with a single measurement). Therefore, the replicates make minimally and moderately active compounds simpler to detect. Two types of replicates exist: technical and biological ones [51] . Technical replicates, which address the variability of the process, are repeated measurements of the same sample that represent 8 independent measures of the random noise associated with equipment or protocols. Biological replicates, which mainly address the variability of the population but also reflect the variability of the process, are separate biological samples that were treated using the same protocol. When the sample population is unknown or has a higher variability, more biological replicates are needed. Increasing the number of technical replicates is important for a more variable technical protocol or when new screening equipment is used. Generally, biological variability is considerably greater than technical variability, so it is to our advantage to commit resources to sampling biologically relevant variables [51] . When planning for replication, researchers have to determine the proportion of variability induced by each experimental step to design statistically independent replicates and distribute the capacity for replication of the experiment across steps.
Recognizing that obtaining even the minimal requirement of two replicates can be prohibitively expensive for some screens, Murie et al. [52] introduced the single assay-wide variance experimental (SAVE) design which can generate statistical tests of biological activity based on replication of only a small subset of plates. 
Identification of hits
The identification of hits is the primary goal of any HTS/HCS campaign. Some screeners select as screening positives a fixed number, or a fixed percentage, of top scoring compounds.
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Compounds whose activity exceeds a fixed percent-of-control threshold may also be considered as hits [8, 54] . A wide range of more sophisticated hit identification techniques is available nowadays. Birmingham and colleagues [50] reviewed the existing hit selection methods, which can be classified as small-molecule derived methods and RNAi-specific techniques. Smallmolecule derived methods include: selection of samples whose screening activity exceeds a fixed threshold, which usually equals mean -3 standard deviations for inhibition assays and mean + 3 standard deviations for activation assays [8] ; a robust to outliers improvement of the previous approach, using median instead of mean and median absolute deviation instead of standard deviations [55] ; for assays using replicated measurements, the difference in means between replicates for each condition can be assessed with multiple t-tests [50] ; finally, the Random
Variance Model (RVM), which uses a weighted average of the compound-specific variance and an estimate of the typical variance of all of the compounds, has shown to be appropriate for small molecule HTS data with performance superior to that of standard t-tests [56, 8] . RNAispecific techniques include: quartile-based hit identification procedure, which establishes upper and lower hit selection thresholds based on number of interquartile ranges (i.e., above or below the first and third quartiles of the data) [57] ; an accurate Strictly Standardized Mean Difference (SSMD) method, which computes the ratio between the difference of the means and the standard deviation of the difference between positive and negative controls [58] ; and, the redundant siRNA Activity (RSA) analysis method, designed for screeners interested in information about multiple RNAi reagents tested for each gene, which assigns p-values to all reagents of a single gene [59] .
Data normalization techniques which correct for overall plate bias only
Data normalization in HTS consists in data transformation allowing for data comparability across different plates of the same assay [50] . The following simple types of data normalization, which do not correct for spatial systematic biases, are commonly used in screening technologies.
Control Normalization is a control-based normalization method using the measurements of both positive and negative controls (Formula 2). 
where ij x is the raw measurement of the compound located in well (i, j), ij x is the normalized value of the raw measurement ij x , pos  is the mean of positive controls of the plate and neg  is the mean of negative controls of the plate.
Median Percent Inhibition (MPI) normalization is carried out as follows (Formula 3):
where med is the median of all measurements of the plate.
Z-score normalization is defined as follows (Formula 4):
,
where  and  are, respectively, the mean and the standard deviation of all measurements of the plate.
Robust Z-score normalization can account for different scale and variability effects across HTS plates. It is less likely to produce biased scores because of outlying values of highly active compounds. Robust Z-score normalization is similar to Z-score except that the median is used instead of the mean and the median absolute deviation (MAD) is considered instead of the standard deviation to obtain the outlier resistant dispersion estimates (Formula 5):
where MAD is the median absolute deviation of measurements of the plate.
Systematic error detection tests
Several error correction methods and software have been recently developed to minimize the impact of systematic bias [7] . These methods and software should, however, be used with caution. Makarenkov et al. [33] demonstrated that systematic error correction methods can introduce systematic bias when applied on error-free HTS data. The introduced bias may be less important as in the case of the well correction procedure [33] or very important as in the case of the B-score method [3] . Thus, the presence or absence of systematic bias in raw HTS data must be first confirmed by the appropriate statistical tests [7, [60] [61] [62] . Systematic error detection tests that work well with screening data are summarized below.
Welch's t-test:
This test is based on the classical two-sample Welch's t-test for the case of samples with various sizes and unequal variances [60] . 
goodness-of-fit test:
This test can be used to establish the presence or absence of systematic error in a hit distribution surface [7] . The null hypothesis H 0 here is the same as in Welch's t-test. 
where rj x is the j th value in row r,  is the hits count of the whole hit distribution surface divided by the number of wells ( 
The number of degrees of freedom here is C N -1. Systematic error affecting a particular well location (i, j) and appearing along all plates of the assay can be also identified by computing the χ 2 statistic [7] (Formula 9):
The number of degrees of freedom here is 
Kolmogorov-Smirnov test preceded by Discrete Fourier Transform:
This method consists of Discrete Fourier Transform (DFT) [63] signal analysis method followed by the Kolmogorov-Smirnov (KS) test [64] . It is included in some commercial software intended to detect systematic error in screening data (e.g., in the Array Validator program described in [65] ). The KS test is a non-parametric test having the advantage of making no assumption about the distribution of data.
As recently has been shown, Welch's t-test usually outperforms the 2  goodness-of-fit test and the KS test preceded by DFT in the context of HTS analysis [7] . A comprehensive simulation study involving artificially generated HTS data was carried out to compare the three abovementioned tests in a variety of practical situations. The success rate of the t-test was usually above 90%, regardless the plate size, the type, and the magnitude of systematic error, whereas the values of Cohen's kappa coefficient for this test suggested its superior performance, in the case of large plates and high level of systematic bias [7] . 
Mann-Whitney-Wilcoxon (MWW) test:
As this is a non-parametric test, it does not make assumptions about the underlying data distribution.
Rank products test:
Consider the expression levels of n genes for k 1 independent replicates in sample X 1 , and k 2 independent replicates in sample X 2 . Let X ijm be the expression level of the i th gene in the j th replicate of the m th sample, where ,
By ranking the expression levels X 1jm , X 2jm , …, X njm within each replicate j, we form the vectors R ijm = rank(X ijm ),
The suitable two-sample version of Breitling's Rank products statistic, RP, for the i th gene can then be calculated by using Formula 12 [62, 66] :
. / [67, 68] .
To estimate the magnitude of systematic bias in experimental HTS data, we carried out a series of tests using the data extracted from the largest public HTS/HCS database, ChemBank [14] . Figure (4b) illustrates the average hit distribution surface error rates for raw data. The presence of systematic errors in an assay can be determined through the analysis of its hit distribution surface depicting the total hit counts per well location over all plates of the assay [33] . Thus, we estimated over all assay's plates the number of measurements with the values lower than the µ-cσ threshold, where the mean value µ and the standard deviation σ were computed separately for each plate; the constant c was gradually set to 2.5, 3.0 and 3.5 to account for the most popular hit selection thresholds. Here also, Welch's t-test was used to determine the presence or absence of systematic error. Similarly, Figure ( HTS assays (background-subtracted data were also extracted from ChemBank), and Figure (4d) shows the average hit distribution surface error rates for the background-subtracted data. The Matlab 8.2 package [69] was used in our computations. The presented graphics suggest that the row and column systematic bias is common to experimental HTS assays (i.e., plate-specific error) -at least 30% of rows and columns in the raw data and 20% of rows and columns in the background-subtracted data were affected by systematic bias (Figure 4a and c) . Moreover, systematic error is even more visible when analyzing hit distribution surfaces (i.e., assay-specific error) -at least 50% of raw hit distribution surfaces and 65% of background-subtracted hit distribution surfaces were affected by systematic error (Figure 4b and d) . This section describes the statistical methods that are used for minimizing plate-specific and assay-specific (i.e., across-plate well-location bias) systematic biases in screening technologies.
Most of these methods allow the correction of overall plate bias as well.
R-scores:
This plate-specific correction method [70] relies on Formula 13:
where ijp x is the compound measurement in row i and column j of plate p, p  is the mean of plate p, R ip is the row bias affecting row i of plate p, C jp is the column bias affecting column j of plate p and r ijp is the residual in well (i, j) of plate p. These parameters can be estimated using, for example, the rlm function from the MASS package of the R language [71] . A variant of the B-scores method used in HCS [73] considers the mean true activity value, μ ijp , in well (i, j) in Formula (13), instead of μ p .
Well correction: This assay-specific correction method proceeds by data normalization along the well locations of the assay [33, 42] . At first, Z-score normalization (Formula 4) is performed within each plate of the assay. The following two steps are then carried out. First, a linear leastsquare approximation is performed for the measurements of each well location of the assay (this well-specific approximation is done across all plates of the assay). Second, Z-score normalization of the fitted measurements obtained from regression is carried out independently for each well location of the assay (still across all plates of the assay).
Robust well correction:
This is another assay-specific data correction procedure. Each plate is normalized using robust Z-scores (Formula 5) and then the entire set of plates is ordered by date of processing and a robust regression line is fit to the data. This fitting is carried out independently for each well location across all plates of the assay as in the Well correction method. The obtained normalized residuals are considered as final corrected scores [31] .
SPatial And Well Normalization (SPAWN):
This two-step procedure gradually applies a trimmed mean polish procedure on individual plates in order to minimize row and column systematic effects [77] . The considered statistical model relies on Formula 13. Then, a well normalization step is carried out to determine spatial bias template, SBT ij , which is the median of the scores at well location (i, j) computed over all plates of the assay. The spatial bias template scores are subtracted from the scores obtained by the median polish procedure:
.
Finally, the resulting scores are rescaled by dividing them by the median absolute deviation of the plate.
Thus, SPAWN corrects for both plate-specific and assay-specific biases.
Matrix Error Amendment (MEA) and Partial Mean Polish (PMP):
These algebraic methods are designed to modify only those rows and columns of the given plate that are affected by systematic bias [34] . MEA and PMP methods rely on prior information concerning the presence and absence of systematic error in the rows and columns of the given plate. Such information can be obtained using a specific version of Welch's t-test or the χ 2 goodness-of-fit test (see previous section). One of the main advantages of the PMP method over MP and B-scores [3] is that PMP does not reduce the original data to residuals, keeping the corrected measurements on the same scale with the original ones. Table 1 reports the discussed data normalization techniques recommended for the analysis of HTS and HCS data along with the underlying assumptions regarding their practical application. Table 1 Various plots that use robust statistical indices have been also suggested for detecting shifts and trends across time in large screening campaigns [3] . Systematic bias within plates can be detected with visualization methods such as 2-dimensional heat maps and 3-dimensional wire plots, although typical plate-specific bias patterns are more easily detected with auto-correlation plots that show the degree of correspondence between wells at various "lags" (e.g., adjacent or separated by one well) [31] . Finally and somewhat counterintuitively, screens with few active compounds should show low correlations between replicate plates; for these screens, scatterplots which show high correspondence between replicate plates indicate across-plate well-specific bias rather than good biological reproducibility [31] .
DISCUSSION and CONCLUSION
We reviewed current knowledge on systematic bias affecting raw data in HTS and HCS technologies. First, we discussed the causes of systematic bias and its impact on the selection of correct hits in HTS and HCS experiments. The main steps of HTS and HCS screening protocols were presented along with the subcategories of screening technologies, including small molecule, cDNA and RNAi screens. Positional bias effects characteristic of screening technologies, comprising batch effects, edge effects and well location effects, were discussed in detail. We highlighted that randomization of experimental units and use of replicates can significantly reduce the magnitude of systematic error. Data normalization techniques which correct for overall plate bias were presented, followed by the description of systematic error detection tests specific to screening technologies. Finally, we discussed error correction methods, indicating under which assumptions and for which kind of spatial bias each of them should be used. In particular, we underlined the distinction between the plate-specific and assay-specific systematic biases and pointed out that data correction methods should be applied only if the presence of systematic bias was confirmed by the appropriate statistical tests. Otherwise, an unwanted bias can be introduced into error-free data.
Figure 5
In order to summarize our presentation, we describe here a general data pre-processing and correction protocol ( Figure 5 ), which could be used as a guide by academic and industrial researchers involved in the analysis of current or next generation screening data. The first required step concerns general design of a screening campaign. The compound locations within each plate, as well as over all plates of the assays, should be randomized in order to reduce the impact of systematic bias on the outcome of screening experiments. Moreover, whenever the campaign funding allows, several replicates of the compound library should be screened.
Replicated screens provide both a greater precision of activity measurements and the ability to assess measurement variability [8] . Once the assay measurements have been established, the appropriate data normalization procedure should be carried out to ensure the data comparability over different plates and screening conditions. Afterwards, systematic error detection tests should be carried out to confirm the presence or absence of systematic error in raw data (e.g.,
Welch's t-test or χ 2 goodness-of-fit test). In particular, these tests can be applied to identify: (1) positional effects of systematic error, including row, column and well location biases; (2) error specificity, including plate, batch and assay-specific biases; (3) type of systematic error, including additive (e.g., Robust well correction, SPAWN or PMP methods can be applied to eliminate this type of bias) and multiplicative (e.g., diffusion model can be applied to eliminate this type of bias) biases. If systematic error was not detected in the data, then no any correction method needs to be applied to them to avoid the risk of introduction of additional biases [7] .
Otherwise, the appropriate error correction method, preferably including a success of control step, should be carried out. Once systematic bias is minimized, assay quality estimation and hit identification steps can be carried out. It is worth noting that the plate-specific correction methods (e.g., PMP) can sometimes be applied in combination with the assay-specific correction methods (e.g., Robust well correction). First, Welch's t-test can be carried out independently for each individual plate of the assay to detect the plate's rows and columns affected by systematic bias. The measurements affected by bias can be subsequently corrected by using the PMP method, which keeps the corrected data on the same scale with the original ones. Second, Welch's t-test can be performed over the hit distribution surface of the entire assay. If the test identifies the presence of systematic bias on the surface, the Robust well correction procedure can be carried out to remove the assay-specific bias. An alternative solution to this problem could be provided by the methods which correct for both plate-specific and assay-specific biases (e.g., SPAWN). 
Key Points
 We reviewed current knowledge on systematic bias affecting experimental HTS and HCS data.
 Study design issues and the way in which data are generated are crucial for providing unbiased screening results. Unfortunately, these key steps are often ignored by HTS practitioners.
 Data correction methods should be applied only if the presence of systematic error has been confirmed by the appropriate statistical tests.
 Discussed sources of systematic bias and presented statistical methods and software intended to correct experimental screening data provide a unifying framework when considering new screening technologies.
 We presented a general data pre-processing and correction protocol which can be used as a guide by academic and industrial researchers involved in the analysis of current or next generation screening data. Recommended data pre-processing and correction protocol to be performed prior to the hit identification step in high-throughput and high-content screening.
